Difference between revisions of "Concizumab (Alhemo)"
Jump to navigation
Jump to search
(Created page with "Anti-TFPI antibody ==Supporting data== *'''explorer7:''' Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J,...") |
m |
||
| Line 4: | Line 4: | ||
*'''explorer7:''' Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J, Hald Jacobsen S, Mahlangu J, Mathias M, Nogami K, Skovgaard Rasmussen J, Stasyshyn O, Tran H, Vilchevska K, Villarreal Martinez L, Windyga J, You CW, Zozulya N, Zulfikar B, Jiménez-Yuste V; explorer7 Investigators. Phase 3 Trial of Concizumab in Hemophilia with Inhibitors. N Engl J Med. 2023 Aug 31;389(9):783-794. [https://doi.org/10.1056/nejmoa2216455 link to original article] [https://pubmed.ncbi.nlm.nih.gov/37646676/ PubMed] [https://clinicaltrials.gov/study/NCT04083781 NCT04083781] | *'''explorer7:''' Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J, Hald Jacobsen S, Mahlangu J, Mathias M, Nogami K, Skovgaard Rasmussen J, Stasyshyn O, Tran H, Vilchevska K, Villarreal Martinez L, Windyga J, You CW, Zozulya N, Zulfikar B, Jiménez-Yuste V; explorer7 Investigators. Phase 3 Trial of Concizumab in Hemophilia with Inhibitors. N Engl J Med. 2023 Aug 31;389(9):783-794. [https://doi.org/10.1056/nejmoa2216455 link to original article] [https://pubmed.ncbi.nlm.nih.gov/37646676/ PubMed] [https://clinicaltrials.gov/study/NCT04083781 NCT04083781] | ||
| − | [[ | + | [[Category:Drugs]] |
[[Category:Anti-TFPI antibodies]] | [[Category:Anti-TFPI antibodies]] | ||
[[Category:Inherited coagulopathy medications]] | [[Category:Inherited coagulopathy medications]] | ||
Revision as of 20:11, 3 September 2023
Anti-TFPI antibody
Supporting data
- explorer7: Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J, Hald Jacobsen S, Mahlangu J, Mathias M, Nogami K, Skovgaard Rasmussen J, Stasyshyn O, Tran H, Vilchevska K, Villarreal Martinez L, Windyga J, You CW, Zozulya N, Zulfikar B, Jiménez-Yuste V; explorer7 Investigators. Phase 3 Trial of Concizumab in Hemophilia with Inhibitors. N Engl J Med. 2023 Aug 31;389(9):783-794. link to original article PubMed NCT04083781